Literature DB >> 2179132

Immunoglobulin isotype production by cycling human B lymphocytes in response to recombinant cytokines and anti-IgM.

L Flores-Romo1, M J Millsum, S Gillis, P Stubbs, C Sykes, J Gordon.   

Abstract

Actively cycling populations of purified human tonsilar B lymphocytes were examined for their capacity to secrete IgM, IgA, IgE and IgG of all four subclasses in direct response to recombinant cytokines; in some experiments, monoclonal antibody to IgM (anti-mu) was included in order to explore the influence of antigen receptor ligation on immunoglobulin (Ig) production. Enhanced IgM release was seen on culture of the cycling cells with either interleukin-2 (IL-2), IL-4 or interferon-alpha (IFN-alpha). IL-2 and IFN-alpha also augmented IgA production, whereas IL-4 had no effect on this isotype. IL-4 did, however, encourage the production of the IgG subclasses IgG1, IgG2 and IgG3, while IL-2 augmented IgG1 and IgG3 release and IFN-alpha increased IgG1 levels. IgG4 production, and that of IgE, failed to be perturbed by any of the cytokines assayed. Neither IL-1 alpha, IL-1 beta, IL-5 nor IFN-gamma significantly altered the profile of Ig isotype release. When confronted with anti-mu, cycling B cells demonstrated a marked suppression in IgM production. Suppression could not be overcome by the addition to culture of the normally IgM-promoting IL-4. Concomitant with the reduction in IgM levels, an increase in IgG release was observed. This was comprised of elevations in IgG1 and IgG3. Although not influencing IgA release directly, anti-mu was found to promote increased IgA production in co-culture with either IL-2 or IFN-alpha. The findings are discussed in the context of recent findings on Ig isotype control in both human and murine systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179132      PMCID: PMC1385949     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.

Authors:  S Maruyama; H Kubagawa; M D Cooper
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

2.  Soluble and immobilized anti-Ig antibodies in the regulation of LPS-induced lymphoblasts.

Authors:  D B Symons; C A Clarkson; F J Hall
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

3.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study.

Authors:  R Jefferis; C B Reimer; F Skvaril; G de Lange; N R Ling; J Lowe; M R Walker; D J Phillips; C H Aloisio; T W Wells
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

4.  Inhibition of antibody production in plasmacytoma cells by antigen.

Authors:  A K Abbas; G G Klaus
Journal:  Eur J Immunol       Date:  1977-10       Impact factor: 5.532

5.  Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.

Authors:  D F Jelinek; P E Lipsky
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

Review 6.  Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions.

Authors:  W E Paul
Journal:  FASEB J       Date:  1987-12       Impact factor: 5.191

7.  T cell help in human antigen-specific antibody responses can be replaced by interleukin 2.

Authors:  R E Callard; S H Smith; J G Shields; R J Levinsky
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

8.  B cell maturation factor: effects on various cell populations.

Authors:  C L Sidman; J D Marshall
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

9.  Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assay.

Authors:  J Gordon; M J Millsum; G R Guy; J A Ledbetter
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

10.  Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40.

Authors:  J Gordon; M J Millsum; L Flores-Romo; S Gillis
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

View more
  11 in total

1.  Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression.

Authors:  D M Estes; W Tuo; W C Brown; J Goin
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

2.  Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.

Authors:  Estefania Nova-Lamperti; Prabhjoat Chana; Paula Mobillo; Manohursingh Runglall; Yogesh Kamra; Reuben McGregor; Graham M Lord; Robert I Lechler; Giovanna Lombardi; Maria P Hernandez-Fuentes
Journal:  Transplantation       Date:  2017-03       Impact factor: 4.939

3.  Regulation of human IgG subclass production by cytokines: human IgG subclass production enhanced differentially by interleukin-6.

Authors:  Y Kawano; T Noma; K Kou; I Yoshizawa; J Yata
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

4.  Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2.

Authors:  L M Plitnick; R A Jordan; J A Banas; D M Jelley-Gibbs; M C Walsh; M T Preissler; E J Gosselin
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 5.  Selective IgG subclass deficiency: quantification and clinical relevance.

Authors:  R Jefferis; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

6.  Effect of 12,13-phorbol dibutyrate and ionomycin on defective B cells in common variable immunodeficiency.

Authors:  A Franz; A Bryant; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

7.  Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.

Authors:  M Benkerrou; D W Wara; M Elder; Y Dror; A Merino; B W Colombe; M Garovoy; M J Cowan
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

8.  Immunohistochemical detection of co-localizing cytokine and antibody producing cells in the extrafollicular area of human palatine tonsils.

Authors:  S Hoefakker; E H van 't Erve; C Deen; A J van den Eertwegh; W J Boersma; W R Notten; E Claassen
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

9.  Interleukin-2-induced DNA synthesis and immunoglobulin secretion by resting human tonsillar B cells: effects of protein kinase C activation.

Authors:  A Franz; A Bryant; J Farrant
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

10.  Disodium cromoglycate enhances ongoing immunoglobulin production in vitro in human B cells.

Authors:  H Kimata; A Yoshida; C Ishioka; H Mikawa
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.